Lausanne University Hospital
Lausanne, Canton of Vaud, 1011, Switzerland
NCT Number: NCT03454217
Postoperative pain is usually treated with opioids. Among them, oxycodone is popular in the daily practice as it is administered orally and is easily titrated. However, side-effects include increase duration and frequency of apneic episodes. Some authors believe that tramadol has less impact on these apneic episodes during the first postoperative night, based on a trial that reported conclusive results only during the first 2 postoperative hours. The objective of this randomized controlled trial is to compare the effect of postoperative pain treatment of oxycodone with tramadol on apneic episodes during the first and third postoperative nights.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Lausanne, Canton of Vaud, 1011, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Postoperative pain treatment with oxycodone
Postoperative pain treatment with tramadol
Time frame: Postoperative night 1
Apnea hypopnea index while lying supine
Time frame: Postoperative night 1
Time frame: Postoperative night 1
Time frame: Postoperative night 3
Time frame: Postoperative night 3
Time frame: Postoperative night 3
Time frame: Postoperative day 0, 1, 2 and 3
Time frame: Postoperative day 0, 1, 2 and 3
Centre Hospitalier Universitaire Vaudois
Other
Acronym: TROXAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03919955
Apnea, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT06050720
Apnea, Dyssomnias
Stoke-on-Trent, United Kingdom
View Trial DetailsNCT04875364
Apnea, Dyssomnias
La Jolla, California, United States
View Trial DetailsNCT05197855
Apnea, Dyssomnias
Grenoble, France
View Trial Details